Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors

T. Yoshida, T. Hisamoto, J. Akiba, H. Koga, K. Nakamura, Y. Tokunaga, S. Hanada, H. Kumemura, M. Maeyama, M. Harada, H. Ogata, H. Yano, M. Kojiro, T. Ueno, Akihiko Yoshimura, M. Sata

Research output: Contribution to journalArticle

117 Citations (Scopus)

Abstract

Aberrant activation of the Ras/Raf-1/extracellular-regulated kinase (ERK) pathway has been shown to be involved in the progression of human hepatocellular carcinoma (HCC). However, the mechanism of dysregulation of ERK activation is poorly understood. Recently, we identified Sprouty-related protein with Ena/vasodilator-stimulated phosphoprotein homology-1 domain (Spred) as a physiological inhibitor of the Ras/Raf-1/ERK pathway. In this study, we found that the expression levels of Spred-1 and -2 in human HCC tissue were frequently decreased, comparing with those in adjacent non-tumorous tissue. Moreover, Spred expression levels in HCC tissue were inversely correlated with the incidence of tumor invasion and metastasis. Forced expression of Spred-1 inhibited HCC cell proliferation in vitro and in vivo, which was associated with reduced ERK activation. Spred-1 overexpression also reduced the secretion of matrix metalloproteinase-9 (MMP-9) and MMP-2, which play important roles in tumor invasion and metastasis. In addition, Spred-1 inhibited growth factor-mediated HCC cell motility. These data indicate that the reduction of Spred expression in HCC is one of the causes of the acquisition of malignant features. Thus, Spred could be not only a novel prognostic factor but also a new therapeutic target for human HCC.

Original languageEnglish
Pages (from-to)6056-6066
Number of pages11
JournalOncogene
Volume25
Issue number45
DOIs
Publication statusPublished - 2006 Oct 5
Externally publishedYes

Fingerprint

Phosphoproteins
Hepatocellular Carcinoma
Signal Transduction
Phosphotransferases
Phenotype
Neoplasms
Neoplasm Metastasis
Matrix Metalloproteinase 9
Matrix Metalloproteinases
Cell Movement
Intercellular Signaling Peptides and Proteins
Cell Proliferation
Incidence

Keywords

  • ERK
  • HCC
  • Raf-1
  • Ras
  • Spred
  • Sprouty

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors. / Yoshida, T.; Hisamoto, T.; Akiba, J.; Koga, H.; Nakamura, K.; Tokunaga, Y.; Hanada, S.; Kumemura, H.; Maeyama, M.; Harada, M.; Ogata, H.; Yano, H.; Kojiro, M.; Ueno, T.; Yoshimura, Akihiko; Sata, M.

In: Oncogene, Vol. 25, No. 45, 05.10.2006, p. 6056-6066.

Research output: Contribution to journalArticle

Yoshida, T, Hisamoto, T, Akiba, J, Koga, H, Nakamura, K, Tokunaga, Y, Hanada, S, Kumemura, H, Maeyama, M, Harada, M, Ogata, H, Yano, H, Kojiro, M, Ueno, T, Yoshimura, A & Sata, M 2006, 'Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors', Oncogene, vol. 25, no. 45, pp. 6056-6066. https://doi.org/10.1038/sj.onc.1209635
Yoshida, T. ; Hisamoto, T. ; Akiba, J. ; Koga, H. ; Nakamura, K. ; Tokunaga, Y. ; Hanada, S. ; Kumemura, H. ; Maeyama, M. ; Harada, M. ; Ogata, H. ; Yano, H. ; Kojiro, M. ; Ueno, T. ; Yoshimura, Akihiko ; Sata, M. / Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors. In: Oncogene. 2006 ; Vol. 25, No. 45. pp. 6056-6066.
@article{872570e1dfc74e95bf2aad0b786ba27c,
title = "Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors",
abstract = "Aberrant activation of the Ras/Raf-1/extracellular-regulated kinase (ERK) pathway has been shown to be involved in the progression of human hepatocellular carcinoma (HCC). However, the mechanism of dysregulation of ERK activation is poorly understood. Recently, we identified Sprouty-related protein with Ena/vasodilator-stimulated phosphoprotein homology-1 domain (Spred) as a physiological inhibitor of the Ras/Raf-1/ERK pathway. In this study, we found that the expression levels of Spred-1 and -2 in human HCC tissue were frequently decreased, comparing with those in adjacent non-tumorous tissue. Moreover, Spred expression levels in HCC tissue were inversely correlated with the incidence of tumor invasion and metastasis. Forced expression of Spred-1 inhibited HCC cell proliferation in vitro and in vivo, which was associated with reduced ERK activation. Spred-1 overexpression also reduced the secretion of matrix metalloproteinase-9 (MMP-9) and MMP-2, which play important roles in tumor invasion and metastasis. In addition, Spred-1 inhibited growth factor-mediated HCC cell motility. These data indicate that the reduction of Spred expression in HCC is one of the causes of the acquisition of malignant features. Thus, Spred could be not only a novel prognostic factor but also a new therapeutic target for human HCC.",
keywords = "ERK, HCC, Raf-1, Ras, Spred, Sprouty",
author = "T. Yoshida and T. Hisamoto and J. Akiba and H. Koga and K. Nakamura and Y. Tokunaga and S. Hanada and H. Kumemura and M. Maeyama and M. Harada and H. Ogata and H. Yano and M. Kojiro and T. Ueno and Akihiko Yoshimura and M. Sata",
year = "2006",
month = "10",
day = "5",
doi = "10.1038/sj.onc.1209635",
language = "English",
volume = "25",
pages = "6056--6066",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "45",

}

TY - JOUR

T1 - Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors

AU - Yoshida, T.

AU - Hisamoto, T.

AU - Akiba, J.

AU - Koga, H.

AU - Nakamura, K.

AU - Tokunaga, Y.

AU - Hanada, S.

AU - Kumemura, H.

AU - Maeyama, M.

AU - Harada, M.

AU - Ogata, H.

AU - Yano, H.

AU - Kojiro, M.

AU - Ueno, T.

AU - Yoshimura, Akihiko

AU - Sata, M.

PY - 2006/10/5

Y1 - 2006/10/5

N2 - Aberrant activation of the Ras/Raf-1/extracellular-regulated kinase (ERK) pathway has been shown to be involved in the progression of human hepatocellular carcinoma (HCC). However, the mechanism of dysregulation of ERK activation is poorly understood. Recently, we identified Sprouty-related protein with Ena/vasodilator-stimulated phosphoprotein homology-1 domain (Spred) as a physiological inhibitor of the Ras/Raf-1/ERK pathway. In this study, we found that the expression levels of Spred-1 and -2 in human HCC tissue were frequently decreased, comparing with those in adjacent non-tumorous tissue. Moreover, Spred expression levels in HCC tissue were inversely correlated with the incidence of tumor invasion and metastasis. Forced expression of Spred-1 inhibited HCC cell proliferation in vitro and in vivo, which was associated with reduced ERK activation. Spred-1 overexpression also reduced the secretion of matrix metalloproteinase-9 (MMP-9) and MMP-2, which play important roles in tumor invasion and metastasis. In addition, Spred-1 inhibited growth factor-mediated HCC cell motility. These data indicate that the reduction of Spred expression in HCC is one of the causes of the acquisition of malignant features. Thus, Spred could be not only a novel prognostic factor but also a new therapeutic target for human HCC.

AB - Aberrant activation of the Ras/Raf-1/extracellular-regulated kinase (ERK) pathway has been shown to be involved in the progression of human hepatocellular carcinoma (HCC). However, the mechanism of dysregulation of ERK activation is poorly understood. Recently, we identified Sprouty-related protein with Ena/vasodilator-stimulated phosphoprotein homology-1 domain (Spred) as a physiological inhibitor of the Ras/Raf-1/ERK pathway. In this study, we found that the expression levels of Spred-1 and -2 in human HCC tissue were frequently decreased, comparing with those in adjacent non-tumorous tissue. Moreover, Spred expression levels in HCC tissue were inversely correlated with the incidence of tumor invasion and metastasis. Forced expression of Spred-1 inhibited HCC cell proliferation in vitro and in vivo, which was associated with reduced ERK activation. Spred-1 overexpression also reduced the secretion of matrix metalloproteinase-9 (MMP-9) and MMP-2, which play important roles in tumor invasion and metastasis. In addition, Spred-1 inhibited growth factor-mediated HCC cell motility. These data indicate that the reduction of Spred expression in HCC is one of the causes of the acquisition of malignant features. Thus, Spred could be not only a novel prognostic factor but also a new therapeutic target for human HCC.

KW - ERK

KW - HCC

KW - Raf-1

KW - Ras

KW - Spred

KW - Sprouty

UR - http://www.scopus.com/inward/record.url?scp=33749836283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749836283&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1209635

DO - 10.1038/sj.onc.1209635

M3 - Article

C2 - 16652141

AN - SCOPUS:33749836283

VL - 25

SP - 6056

EP - 6066

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 45

ER -